{"id":"https://openalex.org/W4229445942","doi":"https://doi.org/10.1007/s12325-022-02148-8","title":"Treatment Patterns and Clinical Characteristics of Patients with Systemic Lupus Erythematosus and Musculoskeletal Symptoms: A Retrospective, Observational Study","display_name":"Treatment Patterns and Clinical Characteristics of Patients with Systemic Lupus Erythematosus and Musculoskeletal Symptoms: A Retrospective, Observational Study","publication_year":2022,"publication_date":"2022-05-09","ids":{"openalex":"https://openalex.org/W4229445942","doi":"https://doi.org/10.1007/s12325-022-02148-8","pmid":"https://pubmed.ncbi.nlm.nih.gov/35534786","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9239948"},"language":"en","primary_location":{"id":"doi:10.1007/s12325-022-02148-8","doi":"https://doi.org/10.1007/s12325-022-02148-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-022-02148-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-022-02148-8.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s12325-022-02148-8.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091855793","display_name":"Natalia Bello","orcid":"https://orcid.org/0000-0001-5042-9460","observed_orcids":["https://orcid.org/0000-0001-5042-9460"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Natalia Bello","raw_affiliation_strings":["Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. bello_natalia@lilly.com","Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. bello_natalia@lilly.com","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056974016","display_name":"Julie A. Birt","orcid":"https://orcid.org/0000-0001-6814-7031","observed_orcids":["https://orcid.org/0000-0001-6814-7031"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie A. Birt","raw_affiliation_strings":["Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jennifer Workman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Workman","raw_affiliation_strings":["Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013153243","display_name":"Xian Zhou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105783","display_name":"Syneos Health (United States)","ror":"https://ror.org/01r74wp43","country_code":"US","type":"company","lineage":["https://openalex.org/I4210105783"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xian Zhou","raw_affiliation_strings":["Syneos Health, Morrisville, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Syneos Health, Morrisville, USA","institution_ids":["https://openalex.org/I4210105783"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062689189","display_name":"Jorge Alfonso Ross Terres","orcid":"https://orcid.org/0000-0003-3722-5062","observed_orcids":["https://orcid.org/0000-0003-3722-5062"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jorge A. Ross-Terres","raw_affiliation_strings":["Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082713013","display_name":"Michelle Petri","orcid":"https://orcid.org/0000-0003-1441-5373","observed_orcids":["https://orcid.org/0000-0003-1441-5373"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Petri","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Baltimore, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Baltimore, USA","institution_ids":["https://openalex.org/I145311948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5091855793"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":{"value":4190,"currency":"USD","value_usd":4190},"fwci":2.3565,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.89122032,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"39","issue":"7","first_page":"3131","last_page":"3145"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":1.0},{"id":"https://openalex.org/keywords/musculoskeletal-symptoms","display_name":"musculoskeletal symptoms","score":0.9049999713897705},{"id":"https://openalex.org/keywords/arthritis","display_name":"arthritis","score":0.8579999804496765},{"id":"https://openalex.org/keywords/joint-pain","display_name":"joint pain","score":0.9940000176429749},{"id":"https://openalex.org/keywords/corticosteroid-use","display_name":"corticosteroid use","score":0.8529999852180481},{"id":"https://openalex.org/keywords/prednisone-dose","display_name":"prednisone dose","score":0.9169999957084656},{"id":"https://openalex.org/keywords/immunosuppressive-drugs","display_name":"immunosuppressants","score":0.9259999990463257},{"id":"https://openalex.org/keywords/antimalarial-drugs","display_name":"antimalarial drugs","score":0.8880000114440918},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9639999866485596},{"id":"https://openalex.org/keywords/biologics","display_name":"biologics","score":0.902999997138977},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.9070000052452087},{"id":"https://openalex.org/keywords/selena-sledai","display_name":"SELENA-SLEDAI","score":0.9070000052452087}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9698536992073059},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7180988788604736},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.6841220259666443},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.6246533393859863},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5749171376228333},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.5383992791175842},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.5207514762878418},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4935396909713745},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4934753179550171},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.4808431565761566},{"id":"https://openalex.org/C2775915377","wikidata":"https://www.wikidata.org/wiki/Q188297","display_name":"Lupus erythematosus","level":3,"score":0.4754497706890106},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.44635140895843506},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4153137803077698},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.28399425745010376},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1112983226776123},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000305","descriptor_name":"Adrenal Cortex Hormones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001168","descriptor_name":"Arthritis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D008180","descriptor_name":"Lupus Erythematosus, Systemic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s12325-022-02148-8","doi":"https://doi.org/10.1007/s12325-022-02148-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-022-02148-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-022-02148-8.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9239948","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9239948","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Adv Ther","raw_type":"Text"},{"id":"pmid:35534786","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35534786","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s12325-022-02148-8","doi":"https://doi.org/10.1007/s12325-022-02148-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-022-02148-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-022-02148-8.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5520316217","display_name":null,"funder_award_id":"NIH-R01","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G7442824540","display_name":"Hopkins Lupus Cohort","funder_award_id":"R01AR069572","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320310145","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4229445942.pdf","grobid_xml":"https://content.openalex.org/works/W4229445942.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W143178846","https://openalex.org/W2013628716","https://openalex.org/W2018939131","https://openalex.org/W2024739358","https://openalex.org/W2058646103","https://openalex.org/W2062320562","https://openalex.org/W2115753936","https://openalex.org/W2141455950","https://openalex.org/W2149063533","https://openalex.org/W2163937136","https://openalex.org/W2166521431","https://openalex.org/W2471329098","https://openalex.org/W2586100826","https://openalex.org/W2599738383","https://openalex.org/W2727017059","https://openalex.org/W2745116001","https://openalex.org/W2810785080","https://openalex.org/W2904663386","https://openalex.org/W2927871970","https://openalex.org/W2979698216","https://openalex.org/W2981671253","https://openalex.org/W3013296593","https://openalex.org/W3114182134","https://openalex.org/W3143803880","https://openalex.org/W3154444342","https://openalex.org/W4239942957"],"related_works":["https://openalex.org/W4406810389","https://openalex.org/W2910253201","https://openalex.org/W2471329098","https://openalex.org/W3032932198","https://openalex.org/W4297374883","https://openalex.org/W3174779218","https://openalex.org/W2724829678","https://openalex.org/W3046441137","https://openalex.org/W7160872611","https://openalex.org/W4392875289"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Musculoskeletal":[1],"(MSK)":[2],"symptoms,":[3],"including":[4],"arthritis":[5,73,219],"and":[6,30,39,98,130,159,189,227],"arthralgia,":[7],"are":[8],"common":[9],"manifestations":[10,216],"of":[11,17,33,56,75,78,166,173,181,214,224,251],"systemic":[12],"lupus":[13],"erythematosus":[14],"(SLE);":[15],"definitions":[16],"activity":[18,42,123,232],"patterns":[19,32,43,100],"in":[20,80,176,198,233],"SLE":[21,59],"differ":[22],"across":[23],"studies.":[24],"This":[25,49,208],"study":[26],"described":[27,102],"clinical":[28],"characteristics":[29,97],"treatment":[31,99],"patients":[34,57,104,140,167,234],"with":[35,58,65,105,235],"SLE-MSK":[36,117,136],"over":[37,110,148],"time":[38],"by":[40,69,185],"disease":[41,122,231],"from":[44,60],"a":[45,54,240,248],"real-world":[46],"setting.":[47],"METHODS:":[48],"retrospective":[50],"descriptive":[51,209],"analysis":[52,210],"includes":[53],"subset":[55],"the":[61,72,76,111,116,149,177,212,221],"Hopkins":[62],"Lupus":[63,82,86,93],"Cohort":[64],"identified":[66],"MSK":[67],"involvement":[68],"scores":[70],"on":[71,120,220],"domain":[74],"Safety":[77],"Estrogens":[79],"Systemic":[81],"Erythematosus":[83,87],"National":[84],"Assessment-Systemic":[85],"Disease":[88],"Activity":[89,94],"Index":[90],"(SELENA-SLEDAI)":[91],"or":[92],"Index.":[95],"Clinical":[96],"were":[101,152],"for":[103,115,242],"at":[106],"least":[107],"two":[108],"visits":[109],"observation":[112,150],"period":[113,151],"(2010-2019)":[114],"population":[118],"based":[119],"three":[121],"patterns:":[124],"chronically":[125],"active":[126],"(MSK-CA),":[127],"relapsing-remitting":[128],"(MSK-RR),":[129],"long":[131],"quiescence":[132],"(MSK-LQ).":[133],"RESULTS:":[134],"The":[135,143,170],"subpopulation":[137],"included":[138],"664":[139],"(4069":[141],"person-years).":[142],"most":[144],"frequently":[145],"used":[146,168],"medications":[147],"antimalarials":[153],"(95%),":[154],"corticosteroids":[155,174],"(92%),":[156],"immunosuppressants":[157],"(58%),":[158],"nonsteroidal":[160],"anti-inflammatory":[161],"drugs":[162],"(NSAIDs)":[163],"(48%);":[164],"7%":[165],"biologics.":[169],"highest":[171],"use":[172,223,250],"was":[175,195],"MSK-CA":[178,204],"group":[179],"(90.5%":[180],"follow-up":[182],"time),":[183],"followed":[184],"MSK-":[186],"RR":[187],"(83.9%),":[188],"MSK-LQ":[190],"(46.5%).":[191],"Mean":[192],"prednisone":[193],"dose":[194],"significantly":[196],"higher":[197],"MSK-RR":[199],"(8.5":[200],"mg)":[201],"compared":[202],"to":[203,229],"(6.5":[205],"mg).":[206],"CONCLUSIONS:":[207],"highlights":[211],"impact":[213],"prevalent":[215],"such":[217],"as":[218],"chronic":[222],"corticosteroids,":[225],"immunosuppressants,":[226],"NSAIDs":[228],"manage":[230],"SLE,":[236],"suggesting":[237],"there":[238],"is":[239],"need":[241],"new":[243],"therapeutic":[244],"options":[245],"that":[246],"enable":[247],"lower":[249],"medication":[252],"when":[253],"treating":[254],"lupus.":[255]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-11T00:00:00"}